Acquisition - January 9, 2023
AstraZeneca to acquire CinCor Pharma
AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. The acquisition will bolster AstraZeneca’s cardiorenal pipeline by adding CinCor’s candidate drug, baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) for blood pressure lowering […]
Acquisition - December 12, 2022
SynAct acquires TXP Pharma and carries out a directed share issue
SynAct Pharma has entered into a conditional agreement on acquisition of TXP Pharma, a Swiss-incorporated biotech company researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The purchase price consists of a fixed purchase price of SEK 136 million and a potential additional purchase price of SEK 55 million, where the […]
Acquisition - December 2, 2022
AstraZeneca to acquire Neogene Therapeutics
AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company focusing on the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts) that offer a novel cell therapy approach for targeting cancer. With a shared goal of bringing cell therapies to patients with solid tumors, Neogene’s expertise in TCR-T discovery, […]
Acquisition - October 31, 2022
Curida acquires biologics manufacturer Diatec
Through the acquisition of Norwegian company Diatec, Curida takes the first steps into biological production. The acquisition strengthens the base on which Curida aims to grow further in the international CDMO market, it states. Before the acquisition, Curida provides manufacturing and development services out of two sites in Norway, and exports to more than 80 […]
Acquisition - October 14, 2022
Cytel acquires SDS Life Science and SDS MedteQ
The US company has announced an agreement to acquire SDS Life Science AB and SDS MedteQ AB. With SDS Life Science and SDS MedteQ supporting more than 100 biomedical sponsors in Scandinavia, in addition to several multinational pharmaceutical companies, the acquisition continues Cytel’s rapid growth into new global markets, the company states in a press […]
Acquisition - September 5, 2022
Center for Translational Research acquires Admescope’s Swedish operation
Center for Translational Research AB acquires Admescope’s Swedish operation (changing name to Metasafe) and strengthens collaboration with Admescope and Symeres. Center for Translational Research CTR is a group of complementary life science service companies providing expert services and advice within product development. The services provided by Admescope Sweden/Metasafe complements well the current offerings and will […]